JP2016515586A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016515586A5 JP2016515586A5 JP2016505594A JP2016505594A JP2016515586A5 JP 2016515586 A5 JP2016515586 A5 JP 2016515586A5 JP 2016505594 A JP2016505594 A JP 2016505594A JP 2016505594 A JP2016505594 A JP 2016505594A JP 2016515586 A5 JP2016515586 A5 JP 2016515586A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- novyi
- unit dose
- cfu
- human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020109387A JP7445893B2 (ja) | 2013-03-29 | 2020-06-25 | ヒトにおける固形腫瘍の処置のためのＣ．ｎｏｖｙｉ |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361806497P | 2013-03-29 | 2013-03-29 | |
| US61/806,497 | 2013-03-29 | ||
| PCT/US2014/032196 WO2014160950A1 (en) | 2013-03-29 | 2014-03-28 | C. novyi for the treatment of solid tumors in humans |
Related Child Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017025263A Division JP2017088619A (ja) | 2013-03-29 | 2017-02-14 | ヒトにおける固形腫瘍の処置のためのＣ．ｎｏｖｙｉ |
| JP2018201792A Division JP2019011376A (ja) | 2013-03-29 | 2018-10-26 | ヒトにおける固形腫瘍の処置のためのＣ．ｎｏｖｙｉ |
| JP2020109387A Division JP7445893B2 (ja) | 2013-03-29 | 2020-06-25 | ヒトにおける固形腫瘍の処置のためのＣ．ｎｏｖｙｉ |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016515586A JP2016515586A (ja) | 2016-05-30 |
| JP2016515586A5 true JP2016515586A5 (enExample) | 2017-03-23 |
| JP6756609B2 JP6756609B2 (ja) | 2020-09-16 |
Family
ID=51625539
Family Applications (7)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016505594A Active JP6756609B2 (ja) | 2013-03-29 | 2014-03-28 | ヒトにおける固形腫瘍の処置のためのＣ．ｎｏｖｙｉ |
| JP2017025263A Pending JP2017088619A (ja) | 2013-03-29 | 2017-02-14 | ヒトにおける固形腫瘍の処置のためのＣ．ｎｏｖｙｉ |
| JP2018201792A Pending JP2019011376A (ja) | 2013-03-29 | 2018-10-26 | ヒトにおける固形腫瘍の処置のためのＣ．ｎｏｖｙｉ |
| JP2020109387A Active JP7445893B2 (ja) | 2013-03-29 | 2020-06-25 | ヒトにおける固形腫瘍の処置のためのＣ．ｎｏｖｙｉ |
| JP2021199949A Pending JP2022022392A (ja) | 2013-03-29 | 2021-12-09 | ヒトにおける固形腫瘍の処置のためのＣ．ｎｏｖｙｉ |
| JP2024034039A Active JP7788114B2 (ja) | 2013-03-29 | 2024-03-06 | ヒトにおける固形腫瘍の処置のためのＣ．ｎｏｖｙｉ |
| JP2025209504A Pending JP2026048721A (ja) | 2013-03-29 | 2025-11-28 | ヒトにおける固形腫瘍の処置のためのＣ．ｎｏｖｙｉ |
Family Applications After (6)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017025263A Pending JP2017088619A (ja) | 2013-03-29 | 2017-02-14 | ヒトにおける固形腫瘍の処置のためのＣ．ｎｏｖｙｉ |
| JP2018201792A Pending JP2019011376A (ja) | 2013-03-29 | 2018-10-26 | ヒトにおける固形腫瘍の処置のためのＣ．ｎｏｖｙｉ |
| JP2020109387A Active JP7445893B2 (ja) | 2013-03-29 | 2020-06-25 | ヒトにおける固形腫瘍の処置のためのＣ．ｎｏｖｙｉ |
| JP2021199949A Pending JP2022022392A (ja) | 2013-03-29 | 2021-12-09 | ヒトにおける固形腫瘍の処置のためのＣ．ｎｏｖｙｉ |
| JP2024034039A Active JP7788114B2 (ja) | 2013-03-29 | 2024-03-06 | ヒトにおける固形腫瘍の処置のためのＣ．ｎｏｖｙｉ |
| JP2025209504A Pending JP2026048721A (ja) | 2013-03-29 | 2025-11-28 | ヒトにおける固形腫瘍の処置のためのＣ．ｎｏｖｙｉ |
Country Status (20)
| Country | Link |
|---|---|
| US (3) | US10617723B2 (enExample) |
| EP (4) | EP3730146B1 (enExample) |
| JP (7) | JP6756609B2 (enExample) |
| KR (1) | KR20160021084A (enExample) |
| CN (2) | CN105451750B (enExample) |
| AU (2) | AU2014240872A1 (enExample) |
| BR (2) | BR122020006408B1 (enExample) |
| CA (2) | CA2908508C (enExample) |
| DK (1) | DK2988760T3 (enExample) |
| ES (3) | ES2815564T3 (enExample) |
| HK (1) | HK1222134A1 (enExample) |
| IL (1) | IL241823B (enExample) |
| MX (1) | MX377118B (enExample) |
| NZ (1) | NZ712691A (enExample) |
| PH (1) | PH12015502260B1 (enExample) |
| RU (1) | RU2718670C2 (enExample) |
| SG (2) | SG11201508071VA (enExample) |
| UA (1) | UA120036C2 (enExample) |
| WO (1) | WO2014160950A1 (enExample) |
| ZA (2) | ZA201507412B (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6712952B2 (ja) * | 2014-03-31 | 2020-06-24 | ザ・ジョンズ・ホプキンス・ユニバーシティー | 固形腫瘍悪性病変を処置するための、抗ｃｔｌａ−４抗体および／または抗ｐｄ−１抗体と組み合わせた、細菌、細菌産物、および他の免疫調節性実体の使用 |
| CN105912930B (zh) * | 2016-04-11 | 2019-02-01 | 北京奇虎科技有限公司 | 移动终端及其系统资源安全控制方法 |
| WO2018039185A1 (en) * | 2016-08-23 | 2018-03-01 | Mayo Foundation For Medical Education And Research | Methods and materials for treating estrogen receptor positive breast cancer |
| AU2018269982B2 (en) * | 2017-05-16 | 2024-06-13 | Biomed Valley Discoveries, Inc. | Compositions and methods for treating cancer with atypical BRAF mutations |
| CN109985039A (zh) * | 2017-12-29 | 2019-07-09 | 深圳微芯生物科技股份有限公司 | 用于治疗白血病的联合用药物及其在制备用于治疗急性髓性白血病的药物中的用途 |
| WO2021231611A1 (en) * | 2020-05-12 | 2021-11-18 | Splash Pharmaceuticals, Inc. | Methods for treating cancer using spl-108 polypeptide based on tp53 mutational status |
| US11717787B2 (en) | 2021-01-04 | 2023-08-08 | Saudi Arabian Oil Company | High free volume membrane for gas separation |
| CN116917009A (zh) | 2021-02-19 | 2023-10-20 | 美国迈胜医疗系统有限公司 | 用于粒子治疗系统的机架 |
| CN113855710B (zh) * | 2021-10-09 | 2024-02-20 | 施慧达药业集团(吉林)有限公司 | 戈氏梭菌联合肿瘤血管生成抑制剂的应用 |
| CN115350145A (zh) * | 2022-09-06 | 2022-11-18 | 华中科技大学同济医学院附属协和医院 | 细菌介导负载二甲双胍的多肽水凝胶在肿瘤免疫治疗中的应用 |
| WO2025163852A1 (ja) * | 2024-02-01 | 2025-08-07 | ミヤリサン製薬株式会社 | Ｃｄ４－ｃｄ８－ｔ細胞を増殖および／または活性化させるための組成物 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4599331A (en) | 1984-12-24 | 1986-07-08 | Syntex (U.S.A.) Inc. | Etianic acids as antiangiogenics |
| ES2041245T3 (es) | 1985-10-23 | 1993-11-16 | The Upjohn Company | Esteroides angioestaticos. |
| US4771042A (en) | 1985-11-25 | 1988-09-13 | The Upjohn Company | Inhibition of angiogenesis involving the coadministration of steroids with heparin or heparin fragments |
| WO1990015816A1 (en) | 1989-06-16 | 1990-12-27 | The Upjohn Company | Suramin type compounds and angiostatic steroids to inhibit angiogenesis |
| CA2425841C (en) | 1991-11-22 | 2006-01-10 | Alcon Laboratories, Inc. | Angiostatic steroids |
| US6905480B2 (en) | 2001-02-28 | 2005-06-14 | Rex Medical, L.P. | Apparatus for delivering ablation fluid to treat lesions |
| AU2002350235A1 (en) * | 2001-11-21 | 2003-06-10 | The Johns Hopkins University | Combination bacteriolytic therapy for the treatment of tumors |
| WO2005018332A1 (en) * | 2003-08-13 | 2005-03-03 | The General Hospital Corporation | Modified microorganisms for anti-cancer therapy |
| US8007782B2 (en) | 2003-10-22 | 2011-08-30 | The Johns Hopkins University | Combination bacteriolytic therapy for the treatment of tumors |
| US20070015738A1 (en) * | 2005-07-15 | 2007-01-18 | Walker Stephen G | Use of non-antibacterial tetracycline formulations for inhibiting bacterial spores from becoming infectious vegetative cells |
| TW200819540A (en) * | 2006-07-11 | 2008-05-01 | Genelux Corp | Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders |
| US9163091B2 (en) * | 2007-05-30 | 2015-10-20 | Lpath, Inc. | Compositions and methods for binding lysophosphatidic acid |
-
2014
- 2014-03-28 EP EP20167187.2A patent/EP3730146B1/en active Active
- 2014-03-28 BR BR122020006408-0A patent/BR122020006408B1/pt active IP Right Grant
- 2014-03-28 WO PCT/US2014/032196 patent/WO2014160950A1/en not_active Ceased
- 2014-03-28 RU RU2015146199A patent/RU2718670C2/ru active
- 2014-03-28 SG SG11201508071VA patent/SG11201508071VA/en unknown
- 2014-03-28 BR BR112015024621-4A patent/BR112015024621B1/pt active IP Right Grant
- 2014-03-28 PH PH1/2015/502260A patent/PH12015502260B1/en unknown
- 2014-03-28 JP JP2016505594A patent/JP6756609B2/ja active Active
- 2014-03-28 ES ES14774988T patent/ES2815564T3/es active Active
- 2014-03-28 CA CA2908508A patent/CA2908508C/en active Active
- 2014-03-28 UA UAA201510523A patent/UA120036C2/uk unknown
- 2014-03-28 MX MX2015013784A patent/MX377118B/es active IP Right Grant
- 2014-03-28 CA CA3206655A patent/CA3206655A1/en active Pending
- 2014-03-28 KR KR1020157031284A patent/KR20160021084A/ko not_active Ceased
- 2014-03-28 ES ES22171112T patent/ES3048113T3/es active Active
- 2014-03-28 EP EP14774988.1A patent/EP2988760B1/en active Active
- 2014-03-28 EP EP22171112.0A patent/EP4108248B1/en active Active
- 2014-03-28 CN CN201480028119.8A patent/CN105451750B/zh active Active
- 2014-03-28 DK DK14774988.1T patent/DK2988760T3/da active
- 2014-03-28 NZ NZ712691A patent/NZ712691A/en unknown
- 2014-03-28 SG SG10201902765VA patent/SG10201902765VA/en unknown
- 2014-03-28 ES ES20167187T patent/ES2922378T3/es active Active
- 2014-03-28 US US14/781,273 patent/US10617723B2/en active Active
- 2014-03-28 CN CN202310166182.9A patent/CN116570628A/zh active Pending
- 2014-03-28 HK HK16110438.1A patent/HK1222134A1/zh unknown
- 2014-03-28 EP EP25202057.3A patent/EP4653054A3/en active Pending
- 2014-03-28 AU AU2014240872A patent/AU2014240872A1/en not_active Abandoned
-
2015
- 2015-09-24 IL IL241823A patent/IL241823B/en active IP Right Grant
- 2015-10-06 ZA ZA2015/07412A patent/ZA201507412B/en unknown
-
2017
- 2017-02-14 JP JP2017025263A patent/JP2017088619A/ja active Pending
- 2017-09-21 ZA ZA2017/06402A patent/ZA201706402B/en unknown
-
2018
- 2018-10-26 JP JP2018201792A patent/JP2019011376A/ja active Pending
-
2019
- 2019-01-17 AU AU2019200276A patent/AU2019200276B2/en active Active
-
2020
- 2020-03-31 US US16/836,003 patent/US11439669B2/en active Active
- 2020-06-25 JP JP2020109387A patent/JP7445893B2/ja active Active
-
2021
- 2021-12-09 JP JP2021199949A patent/JP2022022392A/ja active Pending
-
2022
- 2022-08-02 US US17/816,924 patent/US20220378852A1/en active Pending
-
2024
- 2024-03-06 JP JP2024034039A patent/JP7788114B2/ja active Active
-
2025
- 2025-11-28 JP JP2025209504A patent/JP2026048721A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016515586A5 (enExample) | ||
| RU2015146199A (ru) | C. novyi для лечения солидных опухолей человека | |
| NZ604029A (en) | Methods of treating bladder cancer | |
| JP2015187125A5 (enExample) | ||
| JP2015519329A5 (enExample) | ||
| WO2007084670A8 (en) | Specific therapy using integrin ligands for treating cancer | |
| WO2009010287A3 (en) | Specific therapy and medicament using integrin ligands for treating cancer | |
| EA201650134A1 (ru) | Специфическая сочетанная терапия злокачественных опухолей цитостатиком и его модификатором | |
| JP2020523354A5 (enExample) | ||
| WO2015095834A3 (en) | Cancer treatments using erk1/2 and bcl-2 family inhibitors | |
| JP2020523356A5 (enExample) | ||
| AR090885A1 (es) | Uso de laquinimod en alta dosis para el tratamiento de la esclerosis multiple | |
| JP2016529285A5 (enExample) | ||
| JP2019532047A5 (enExample) | ||
| SA522432668B1 (ar) | طرق لعلاج سرطان الرئة للخلايا الصغيرة بصيغ من لوربينيكتيدين | |
| JP2019526559A5 (enExample) | ||
| JP2019508476A5 (enExample) | ||
| JP2017503846A5 (enExample) | ||
| Mornex et al. | Gemcitabine and radiation therapy in non-small cell lung cancer: state of the art | |
| JP2016505050A5 (enExample) | ||
| MX2023007826A (es) | Metodos que comprenden una dosificacion intermitente fija de cediranib. | |
| RU2012108144A (ru) | Противораковая терапия, направленная против раковых стволовых клеток и форм рака, устойчивых к лечению лекарственными препаратами | |
| WO2010057596A3 (en) | New therapy and medicament using integrin ligands for treating cancer | |
| JP2019509329A5 (enExample) | ||
| RU2023127898A (ru) | C. novyi для лечения солидных опухолей человека |